Axcella Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Axcella Health generated cash of -$69,588,000, which is less than the previous year. Cash used in financing activities reached the amount of $32,238,000 last year. Net change in cash is therefore -$6,427,000.
Cash Flow
| 2017 | -26.86M | -915K | 25.69M |
|---|---|---|---|
| 2018 | -30.71M | -586K | 63.94M |
| 2019 | -50.96M | -117K | 63.66M |
| 2020 | -49.77M | -36.11M | 65.42M |
| 2021 | -54.22M | 3.04M | 3.15M |
| 2022 | -69.58M | 30.92M | 32.23M |
AXLA Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 23.57M | 71.59M | 92.05M | 79.46M | 46.81M | 48.89M |
Operating activities | ||||||
Net income | -81.18M | -64.62M | -56.52M | -59.03M | -36.06M | -30.94M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 412K | 288K | 419K | 662K | 1.07M | 1.38M |
Stock-based compensation expense | 3.58M | 6.24M | 6.28M | 5.82M | 2.77M | 1.24M |
| Deferred income tax benefit | 3.58M | 6.24M | 6.28M | 5.82M | 2.77M | 1.24M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 382K | 2.05M | 311K | 366K | 595K | 40K |
Cash generated by operating activities | -69.58M | -54.22M | -49.77M | -50.96M | -30.71M | -26.86M |
Investing activities | ||||||
Purchases Of Investments | 0 | -23.39M | -35.92M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -426K | -275K | -239K | -136K | -659K | -1.09M |
Acquisitions Net | 0 | -3.32K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 30.92M | 3.04M | -36.11M | -117K | -586K | -915K |
Financing activities | ||||||
Common Stock Issued | 53.49M | 4.77M | 65.32M | 64.54M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -131K | 0 | 0 | 0 | 0 |
Cash used in financing activities | 32.23M | 3.15M | 65.42M | 63.66M | 63.94M | 25.69M |
Net Change In Cash | -6.42M | -48.01M | -20.46M | 12.58M | 32.64M | -2.07M |
Cash at end of period | 17.14M | 23.57M | 71.59M | 92.05M | 79.46M | 46.81M |
| Data source | Data source | Data source | Data source |